Press Releases

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND STOCK OPTION GRANTS.   QUEBEC, July 28, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...

PRESS RELEASE For immediate release Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering use of Thykamine™ for the treatment of Ulcerative Colitis.   QUEBEC, June 15, 2020 – Devonian Health Group Inc. (“Devonian” or the...

PRESS RELEASE For immediate release Devonian Health Group announces completion of Enrollment in its Phase 2 Clinical Trial of Thykamine™ for the Treatment of mild-to-moderate Atopic Dermatitis in adult population.   Last-patient-last-visit took place on June 3rd,...

PRESS RELEASE For immediate release Devonian Health Group Announces Change to its Board of Directors.   QUEBEC, June 5, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused...

PRESS RELEASE For immediate release Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs.   Combination of Devonian’s Botanical Drug expertise with CannTx Life...

PRESS RELEASE For immediate release Devonian Health Group Announces the nomination of Dr André P. Boulet to the American Botanical Drug Association.   Dr Boulet to represent Canada within the organization QUEBEC, May 21st, 2020 – Devonian Health Group Inc....

PRESS RELEASE For immediate release Devonian Health Group Announces the Closing of $1,805,000 Non-Brokered Financing.   QUÉBEC CITY, May 4, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical...

PRESS RELEASE For immediate release Devonian Health Group Announces an Increase to its Non-Brokered Financing to $2,000,000.   QUÉBEC CITY, April 24, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical...

PRESS RELEASE For immediate release Devonian Health Group Announces the Issuance of Securities in Interest Settlement Due to Debenture Holders, a $330,000 Non-Brokered Financing and the Grant of Options.   QUÉBEC CITY, April 22, 2020 – Devonian Health Group Inc....

PRESS RELEASE For immediate release Devonian Health Group Announces R-Spinasome® anti-aging technology global sales and marketing partnership.   QUEBEC, February 11, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage...